Journal of Obstetrics, Gynecology and Cancer Research، جلد ۷، شماره ۲، صفحات ۷۷-۸۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy
چکیده انگلیسی مقاله Background & Objective: Estradiol and misoprostol have been used for the enhancement of transformation zone (TZ) visibility in vaginal colposcopy. However, no consensus has been reached on the superiority of one medication over the other. This study aimed to compare the efficacy of estradiol and misoprostol for the enhancement of TZ visibility in vaginal colposcopy of premenopausal and postmenopausal women. Materials & Methods: In this clinical trial, 78 patients with unsatisfactory colposcopy were randomly divided into three groups. Group 1 (n=25) received 25 µg of vaginal estradiol for 14 days prior to colposcopy. Group 2 (n=27) received 400 µg of misoprostol 12 h prior to colposcopy. Group 3 (n=26) served as the control group and did not receive any medication. Visibility of the TZ, age, body mass index (BMI), history of vaginal delivery, history of sexually transmitted diseases, history of human papillomavirus (HPV), the reason for colposcopy, and drug-related side effects were compared among the three groups and also between premenopausal and postmenopausal women. Data were analyzed using analysis of variance (ANOVA), Kruskal-Wallis, Chi-square, and Fisher's exact tests. Results: The percentage of TZ visibility was 72%, 55.6%, and 26.9% in the estradiol, misoprostol, and control groups, respectively (P=0.005). These values were 70%, 33.3%, and 0%, respectively, in postmenopausal women (P=0.043) and 60%, 72.7%, and 33.3%, respectively, in premenopausal women (P=0.152). Regarding drug-related side effects, there was no statistically significant difference between the three groups (P=0.374). Conclusion: Estradiol was significantly superior to misoprostol for the enhancement of TZ visibility, particularly in postmenopausal women, with no difference regarding side effects.
کلیدواژه‌های انگلیسی مقاله Estradiol, Misoprostol, Colposcopy, Transformation Zone, Visibility
نویسندگان مقاله | Mitra Modares Gilani
Department of Obstetrics and Gynecology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


| Fariba Yarandi
Department of Obstetrics and Gynecology, Yas Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


| Narges Zamani
Department of Obstetrics and Gynecology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


| Shaghayegh Nowroozi
Department of Obstetrics and Gynecology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


| Sara Ramhormozian
Department of Obstetrics and Gynecology, Yas Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


| Elham Shirali
Department of Obstetrics and Gynecology, Yas Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
نشانی اینترنتی http://jogcr.com/browse.php?a_code=A-10-217-1&slc_lang=en&sid=1
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Obstetrics and Gynecology (زنان و زایمان)
نوع مقاله منتشر شده پژوهشی اصیل
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات